GH - Latest News
Guardant Health, Inc. (GH), operates in Healthcare / Medical - Diagnostics & Research, trades on NASDAQ.
Market capitalization stands near $23.94B. Beta to the broader market is 1.58.
The article list below shows the most recent GH headlines from major financial news vendors. For options traders, the most actionable items are earnings releases, analyst rating changes, M&A activity, and regulatory filings - each can drive a meaningful repricing of implied volatility and shift dealer hedging flow. Pair the news context with the implied-volatility skew and gamma exposure views to see whether the options market has already priced in the headline.
Recent GH Headlines
The Top HealthTech Questions Landing on Our Desks
etftrends.com - Sep 30, 2026
Strong performance across the healthtech sector over the past two quarters has sparked renewed market interest in medical innovation. Given the volum
Reviewing Guardant Health (NASDAQ:GH) & CorVel (NASDAQ:CRVL)
defenseworld.net - Sep 28, 2026
CorVel (NASDAQ: CRVL - Get Free Report) and Guardant Health (NASDAQ: GH - Get Free Report) are both healthcare companies, but which is the better stoc
AI-Fueled Precision Oncology Firm Guardant Health Is In Focus. Here's Why.
investors.com - Sep 21, 2026
Earning a spot on the IBD Leaderboard and IBD 50, Guardant Health stress tests a breakout.
Guardant Health (NASDAQ:GH) versus InfuSystem (NYSE:INFU) Critical Review
defenseworld.net - Sep 21, 2026
Guardant Health (NASDAQ: GH - Get Free Report) and InfuSystem (NYSE: INFU - Get Free Report) are both healthcare companies, but which is the superior
Guardant Health (NASDAQ:GH) Director Sells $144,550.00 in Stock
defenseworld.net - Sep 20, 2026
Guardant Health, Inc. (NASDAQ: GH - Get Free Report) Director Alex Azar II sold 826 shares of Guardant Health stock in a transaction dated Wednesday,
How News Affects GH Options Pricing
Headlines and scheduled events drive implied volatility in two distinct ways. Pre-event, IV typically inflates as uncertainty about the outcome rises; this is the implied-volatility expansion that creates the long-vol setup. Post-event, IV typically contracts sharply as uncertainty resolves; this is IV crush, which makes premium-selling structures profitable when they survive the underlying move. The size of the crush depends on how stretched pre-event IV is relative to the realized move. Track GH's implied vs realized volatility over the news cycle to size pre-event vs post-event positioning. For ticker-level dealer positioning context, the gamma exposure view shows whether dealers are positioned to amplify or dampen post-news moves.
Frequently asked GH news questions
- What is the latest GH news headline?
- The most recent GH headline (Sep 30, 2026) is "The Top HealthTech Questions Landing on Our Desks". The five most recent stories with summaries and publication times are listed above, sourced from major financial news vendors.
- How fresh is the GH news on this page?
- News rows refresh roughly every 30 minutes during the trading day. The five most recent headlines are listed in publication-time order. Press releases from the company itself typically appear within minutes of the wire release; third-party reporting may lag by 30-60 minutes depending on the source.
- What GH news moves options pricing?
- Three categories move single-name IV most aggressively: scheduled earnings releases (priced into pre-event IV, crushed post-event), unscheduled M&A or strategic announcements (rapid IV expansion, slower decay), and regulatory or legal events (drug-trial readouts, antitrust filings, FDA approvals). Routine news flow (analyst commentary, sector rotation) typically does not move IV meaningfully unless it triggers a cluster of rating changes.
- How can I track unusual GH options activity related to news?
- Unusual options activity often precedes news by hours to days; the canonical signals are volume substantially above the trailing average concentrated in a small number of strikes, atypical put/call skew, and aggressive execution (at-the-ask sweeps or block prints). Cross-reference the per-ticker gamma-exposure and volume-history pages with the news flow above to triangulate informed vs uninformed flow.